报价延迟最少15分钟:2025/10/23 16:15 EDT
盘后时段
|
||||
|
27.5 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
27.5
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.24/0.28
|
|
企业价值
436.54M
|
| 资产负债 |
|
每股账面净值
7.79
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
126.08M
|
|
每股收益
9.13
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/10/23 16:15 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market. |
